UnitedHealth Group Inc (UNH): Today's Featured Health Services Laggard

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

UnitedHealth Group ( UNH) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole was unchanged today. By the end of trading, UnitedHealth Group fell 69 cents (-1.3%) to $51.40 on average volume. Throughout the day, 8.2 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 5.7 million shares. The stock ranged in price between $51.36-$52.24 after having opened the day at $52 as compared to the previous trading day's close of $52.09. Other companies within the Health Services industry that declined today were: Medical Action Industries ( MDCI), down 14.6%, CombiMatrix Corporation ( CBMX), down 10.6%, SunLink Health Systems ( SSY), down 9.1%, and EnteroMedics ( ETRM), down 8.7%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $53.21 billion and is part of the health care sector. The company has a P/E ratio of 9.9, below the S&P 500 P/E ratio of 17.7. Shares are down 4% year to date as of the close of trading on Monday. Currently there are 14 analysts that rate UnitedHealth Group a buy, no analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, increase in net income, revenue growth, notable return on equity and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Urologix ( ULGX), up 8.6%, BioClinica ( BIOC), up 7.1%, Syneron Medical ( ELOS), up 6.8%, and Bovie Medical Corporation ( BVX), up 6.6%, were all gainers within the health services industry with Boston Scientific ( BSX) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

HOLIDAY SPECIAL: Let Jim Cramer show you every trade he is making in his $2.5 Million portfolio. Join now for 14-days FREE. Sign up today to get e-mail alerts before every trade.
null

If you liked this article you might like

Tenet Healthcare Is 'Heavily Indebted,' Jim Cramer Warns

Cramer: Market Rushes to Refill Its Glass

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Boeing, Pure Storage, Activision Blizzard: 'Mad Money' Lightning Round

The Makings of Another Huge Rebound?